Fermenta Biotech Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Prashant Nagre

Chief Executive Officer (CEO)

₹16.1m

Compensación total

Porcentaje del salario del CEO	89.1%
Permanencia del CEO	5.2yrs
Participación del CEO	n/a
Permanencia media de la dirección	5.2yrs
Promedio de permanencia en la Junta Directiva	4.9yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Prashant Nagre en comparación con los beneficios de Fermenta Biotech?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	₹85m
Jun 30 2024	n/a	n/a	-₹307m
Mar 31 2024	₹16m	₹14m	-₹231m
Dec 31 2023	n/a	n/a	-₹207m
Sep 30 2023	n/a	n/a	-₹670m
Jun 30 2023	n/a	n/a	-₹471m
Mar 31 2023	₹18m	₹16m	-₹511m
Dec 31 2022	n/a	n/a	-₹401m
Sep 30 2022	n/a	n/a	-₹107m
Jun 30 2022	n/a	n/a	₹15m
Mar 31 2022	₹15m	₹14m	₹154m
Dec 31 2021	n/a	n/a	₹152m
Sep 30 2021	n/a	n/a	₹330m
Jun 30 2021	n/a	n/a	₹432m
Mar 31 2021	₹23m	n/a	₹455m
Dec 31 2020	n/a	n/a	₹412m
Sep 30 2020	n/a	n/a	₹411m
Jun 30 2020	n/a	n/a	₹591m
Mar 31 2020	₹19m	n/a	₹595m
Dec 31 2019	n/a	n/a	₹877m
Sep 30 2019	n/a	n/a	₹1b
Jun 30 2019	n/a	n/a	₹1b
Mar 31 2019	₹28m	n/a	₹1b

Compensación vs. Mercado: La compensación total de Prashant($USD191.09K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD42.72K).

Compensación vs. Ingresos: La compensación de Prashant ha sido consistente con los resultados de la empresa en el último año.

CEO

Prashant Nagre (53 yo)

5.2yrs

Permanencia

₹16,111,155

Compensación

Mr. Prashant Prabhakar Nagre serves as an Additional Director of Fermenta Biotech Limited since May 6, 2021 and serves as its Managing Director since May 9, 2021. He served as Chief Executive Officer at Fe...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Prashant Nagre	MD & Additional Director	5.2yrs	₹16.11m	sin datos
Krishna Datla	Executive Vice-Chairman	19.5yrs	₹21.11m	34.01% ₹ 3.7b
Sumesh Gandhi	Group Chief Financial Officer	7.8yrs	₹8.73m	sin datos
Srikant Sharma	Company Secretary & VP of Legal	no data	₹6.07m	sin datos
Satish Varma Nadimpally	Executive Director	no data	₹15.39m	11.73% ₹ 1.3b
Anupama Desai	Executive Director	5.2yrs	₹10.94m	8.7% ₹ 947.2m
V. Raveendranath	Head of Human Resources & Administration	17.9yrs	sin datos	sin datos
Varadvinayak Khambete	Compliance Officer & Nodal Officer	less than a year	sin datos	sin datos

5.2yrs

Permanencia media

49yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 506414 es experimentado (5.2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Prashant Nagre	MD & Additional Director	3.5yrs	₹16.11m	sin datos
Krishna Datla	Executive Vice-Chairman	19.5yrs	₹21.11m	34.01% ₹ 3.7b
Satish Varma Nadimpally	Executive Director	21.3yrs	₹15.39m	11.73% ₹ 1.3b
Anupama Desai	Executive Director	5.2yrs	₹10.94m	8.7% ₹ 947.2m
Pramod Kasat	Independent Director	2.5yrs	₹600.00k	sin datos
Rajeshwari Datla	Non-Executive Director	19.3yrs	₹800.00k	2.02% ₹ 220.3m
Pradeep Chandan	Independent Non-Executive Chairman	less than a year	₹100.00k	sin datos
Rajashri Santosh Ojha	Non-Executive Independent Director	4.6yrs	₹600.00k	sin datos

4.9yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de 506414 se considera experimentada (4.9 años de antigüedad promedio).

Fermenta Biotech Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Fermenta Biotech Limited Announces Company Secretary Changes

Less than half of directors are independent

Fermenta Biotech Limited, Annual General Meeting, Sep 29, 2023

Less than half of directors are independent

Fermenta Biotech Limited, Annual General Meeting, Aug 12, 2022

Less than half of directors are independent

Recent updates

Second quarter 2025 earnings released: EPS: ₹3.94 (vs ₹9.63 loss in 2Q 2024)

Fermenta Biotech Limited to Report Q2, 2025 Results on Nov 14, 2024

New minor risk - Share price stability

Fermenta Biotech Limited to Report Q1, 2025 Results on Aug 12, 2024

Upcoming dividend of ₹1.25 per share

Full year 2024 earnings released: ₹7.99 loss per share (vs ₹17.70 loss in FY 2023)

Fermenta Biotech Limited Announces Company Secretary Changes

Fermenta Biotech Limited to Report Q4, 2024 Results on May 27, 2024

Less than half of directors are independent

Third quarter 2024 earnings released: EPS: ₹3.41 (vs ₹12.97 loss in 3Q 2023)

Second quarter 2024 earnings released: ₹9.63 loss per share (vs ₹2.79 loss in 2Q 2023)

Fermenta Biotech Limited to Report Q2, 2024 Results on Nov 08, 2023

Fermenta Biotech Limited Approves Dividend for the Financial Year Ended March 31, 2023, Payable on or Before October 10, 2023

Fermenta Biotech Limited, Annual General Meeting, Sep 29, 2023

Fermenta Biotech Limited to Report Q1, 2024 Results on Aug 11, 2023

Fermenta Biotech Limited Announces Suspension of Operations Due to Heavy Rainfall in Himachal Pradesh

Fermenta Biotech Limited Recommends Final Equity Dividend for the Financial Year Ended March 31, 2023

Full year 2023 earnings released: ₹17.85 loss per share (vs ₹5.36 profit in FY 2022)

Fermenta Biotech Limited to Report Q4, 2023 Results on May 29, 2023

Third quarter 2023 earnings released: ₹12.97 loss per share (vs ₹2.79 loss in 3Q 2022)

Red Brick It Support Services LLP acquired premises in Thane One Building from Fermenta Biotech Limited (BSE:506414) for Rs 138.85 million.

Second quarter 2023 earnings released: ₹2.79 loss per share (vs ₹1.56 profit in 2Q 2022)

Less than half of directors are independent

Fermenta Biotech Limited to Report Q2, 2023 Results on Nov 11, 2022

Investor sentiment improved over the past week

Fermenta Biotech Limited to Report Q1, 2023 Results on Aug 12, 2022

Upcoming dividend of ₹1.25 per share

Full year 2022 earnings released: EPS: ₹5.36 (vs ₹15.78 in FY 2021)

Fermenta Biotech Limited, Annual General Meeting, Aug 12, 2022

Full year 2022 earnings released: EPS: ₹5.36 (vs ₹15.78 in FY 2021)

Fermenta Biotech Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022, Payable on or Before August 22, 2022

Fermenta Biotech Limited to Report Q4, 2022 Results on May 30, 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Fermenta Biotech Limited to Report Q3, 2022 Results on Feb 14, 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Upcoming dividend of ₹2.50 per share

Full year 2021 earnings released: EPS ₹15.78 (vs ₹20.64 in FY 2020)

Full year 2021 earnings released: EPS ₹15.78 (vs ₹20.64 in FY 2020)

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹3.40 (vs ₹3.35 in 3Q 2020)

New 90-day low: ₹283

Fermenta Biotech Limited to Report Q3, 2021 Results on Feb 11, 2021

New 90-day low: ₹291

Market bids up stock over the past week

Market bids up stock over the past week

Second quarter 2021 earnings released: EPS ₹5.10

New 90-day low: ₹297

Fermenta Biotech Limited to Report Q2, 2021 Results on Nov 14, 2020

First quarter earnings released

New 90-day high - ₹428

Fermenta Biotech Limited to Report Q1, 2021 Results on Sep 14, 2020

New 90-day high - ₹379

Fermenta Biotech Limited to Report Fiscal Year 2020 Results on Aug 28, 2020

New 90-day high - ₹304

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad